Aguilar Richard's Form 4 filing
Cano Health, Inc. (CANO) · filed Aug 31, 2021
- Accession no.
- 0000899243-21-034608
- Filed
- Aug 31, 2021
- Trade date
- Aug 25-30, 2021
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market purchases total $1.48M. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aguilar RichardCIK 0001865481 | Officer (Chief Clinical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2021 | Class A Common Stock | PPurchaseAcquired | +8,121 | $3.62F3 | +$29,398.02 | 8,121 | Direct | |
| Aug 26, 2021 | Class A Common Stock | PPurchaseAcquired | +38,589 | $3.81F4 | +$147,024.09 | 46,710 | Direct | |
| Aug 30, 2021 | Class A Common Stock | PPurchaseAcquired | +651,163 | $10.75F7 | +$7,000,002.25 | 651,163 | Direct | |
| Aug 30, 2021 | Class A Common Stock | PPurchaseAcquired | +651,163 | $10.75F7 | +$7,000,002.25 | 651,163 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.59 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.47 to $12.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
Referenced by the price of 1 transaction in Table II.
- F4
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.55 to $3.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
Referenced by the price of 1 transaction in Table II.
- F7
These securities were purchased from an existing stockholder of the Issuer in a private transaction. The combined price per each one share of Class B Common Stock and one PCIH Common Unit was negotiated on an arm's-length basis and determined based on the opening price of Cano's Class A Common Stock on August 16, 2021.
Referenced by the price of 2 transactions in Table II.